Navigation Links
The New England Journal of Medicine Publishes EURIDIS/ADONIS Study Results Showing Dronedarone Maintained Sinus Rhythm in Patients With Atrial Fibrillation or Flutter With no Observed Pro-Arrhythmia
Date:9/5/2007

and during 9 scheduled visits over 12 months. Regular ECG's were also transmitted when patients were asymptomatic. The primary end point was time from randomization to first documented AF/AFL recurrence.

About Dronedarone (MULTAQ(TM))

Dronedarone is a novel multi-channel blocker, anti-arrhythmic drug (AAD) under development, discovered and developed by sanofi-aventis for the treatment of atrial fibrillation and atrial flutter.

About sanofi-aventis

Sanofi-aventis is one of the world leaders in the pharmaceutical industry, ranking number one in Europe. Backed by a world-class R&D organization, sanofi-aventis is developing leading positions in seven major therapeutic areas: cardiovascular, thrombosis, oncology, metabolic diseases, central nervous system, internal medicine and vaccines. Sanofi-aventis is listed in Paris (EURONEXT: SAN) and in New York (NYSE: SNY).

Forward Looking Statements

This press release contains forward-looking statements as defined in the Private Securities Litigation Reform Act of 1995, as amended. Forward-looking statements are statements that are not historical facts. These statements include financial projections and estimates and their underlying assumptions, statements regarding plans, objectives, intentions and expectations with respect to future events, operations, products and services, and statements regarding future performance. Forward-looking statements are generally identified by the words "expects," "anticipates," "believes," "intends," "estimates," "plans" and similar expressions. Although sanofi-aventis' management believes that the expectations reflected in such forward-looking statements are reasonable, investors are cautioned that forward-looking information and statements are subject to various risks and uncertainties, many of which are difficult to predict and generally beyond the control of sanofi-aventis, that could cause actual results and developments to differ materially from those e
'/>"/>

SOURCE sanofi-aventis
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine news :

1. Arsenic May Have Been Responsible For The Madness Of King George III Of England
2. Indian Surgeon Conducts 70 Surgeries During His Holidays In England
3. Illegal Drug Use In England Mounting Up At An Alarming Rate
4. What Will Primary Care Look Like In England by 2015?
5. Ayurvedic Massage & English Food May Cheer England Team
6. Suicide Rates Drop To Lowest Ever In England
7. Head Of The Church Of England Asks NHS To Respect Patient Needs
8. More Accidents on England’s Road - Statistics Revea
9. England in the Grip of Dangerous Alcohol Addiction
10. Increase of Cancer drug usage in England
11. Cancer Drug Banned in England
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/21/2014)... The number of Mirena lawsuits ( ... underway in New Jersey, Bernstein Liebhard LLP reports. , ... involving the birth control IUD have now been filed ... by women who allege spontaneous migration of the device, ... and other complications they were inadequately warned about by ...
(Date:12/21/2014)... Over the past 39 years, NES ... of emergency departments across the nation, from quality of ... translated into an innovative suite of tools, systems, and ... enhance the patient experience. , NES Health, a ... management services for hospitals, announced the development and launch ...
(Date:12/21/2014)... CannabisClassifieds.com celebrates marijuana’s new legal place at the table ... kind, the site has provided its faithful users with everything ... It uniquely combines the benefits of platforms like Craigslist, ... the masses. Assuring the potent herb’s followers it’s well ... approval. , Shane Chattin, Owner of Cannabis Classifieds ...
(Date:12/20/2014)... 21, 2014 BambooIndustry.com is ... the business has announced its bamboo flooring promotion ... best material from certified suppliers, and offers the ... worldwide. In the current promotion, all customers can ... when they say they know BambooIndustry.com from press ...
(Date:12/20/2014)... 2014 Dress company LunaDress has recently announced ... its Christmas Sale, offering big discounts on all of its ... an idea to own a perfect wedding gown. If you ... dress, then come to LunaDress. Many different wedding dress styles ... our website now and enjoy the current special offer, up ...
Breaking Medicine News(10 mins):Health News:Mirena Lawsuits Approach 1,400 in Bergen County Litigation, Bernstein Liebhard LLP Reports 2Health News:Mirena Lawsuits Approach 1,400 in Bergen County Litigation, Bernstein Liebhard LLP Reports 3Health News:NES Health Launches Stipend Program for Emergency Physicians in Training to Financially Assist Emergency Department Doctors While They Learn 2Health News:CannabisClassifieds.com Maintains its “Craigslist for Cannabis” Standing with Website Re-launch 2Health News:Eco-friendy Bamboo Flooring Manufacturer BambooIndustry.com Introduces Its Bamboo Flooring Promotion for 2015 2Health News:2015 Collection of Wedding Dresses from LunaDress Online on Sale Now 2
... studies published in the United States have determined that young ... to smoke. To combat smoking among youth, public health ... depict smoking. A new study from New Zealand, however, ... may not have the intended effect of putting such movies ...
... for Testing by End of School ... ... Education Agency,(TEA) announced today it has selected FITNESSGRAM(R), created by The Cooper,Institute ... annual testing of more than four million Texas,3rd through 12th grade students ...
... E. coli O157:H7 vaccine named "best new veterinary product for livestock" ... ... -, BELLEVILLE, ON, Sept. 27 /PRNewswire-FirstCall/ - Bioniche Life,Sciences ... its vaccine against E. coli,O157:H7 in cattle has been recognized internationally ...
... Product, ABBOTT PARK, Ill., Sept. 27 ... autoimmune diseases, has received the,2007 Galen Prize for ... approved fully human antibody. HUMIRA is approved,for use ... arthritis,psoriatic arthritis, ankylosing spondylitis and moderate to severe ...
... Climb to Conquer Cancer will follow four professional U.S., ... Alaska, NEW YORK, Sept. 27 Fred Hutchinson ... expedition to an unclimbed,mountain in the name of cancer ... expedition. The inaugural Climb to Conquer Cancer, performed ...
... lower their quality of life, survey finds , ... with diabetes, the burden of adhering to their daily ... complications, a U.S. study finds. , University of Chicago ... type 2 diabetes. , As reported in the October ...
Cached Medicine News:Health News:R rating might be unlikely to affect teens exposure to smoking in movies 2Health News:The Cooper Institute's FITNESSGRAM Selected as Statewide Physical Fitness Assessment Tool 2Health News:The Cooper Institute's FITNESSGRAM Selected as Statewide Physical Fitness Assessment Tool 3Health News:The Cooper Institute's FITNESSGRAM Selected as Statewide Physical Fitness Assessment Tool 4Health News:Bioniche Food Safety Vaccine Receives Global Top Honours in Industry Excellence Awards 2Health News:Bioniche Food Safety Vaccine Receives Global Top Honours in Industry Excellence Awards 3Health News:Bioniche Food Safety Vaccine Receives Global Top Honours in Industry Excellence Awards 4Health News:Abbott's HUMIRA(R) (adalimumab) Honored With Prestigious Galen Prize for Innovation in Patient Care 2Health News:Abbott's HUMIRA(R) (adalimumab) Honored With Prestigious Galen Prize for Innovation in Patient Care 3Health News:Abbott's HUMIRA(R) (adalimumab) Honored With Prestigious Galen Prize for Innovation in Patient Care 4Health News:Abbott's HUMIRA(R) (adalimumab) Honored With Prestigious Galen Prize for Innovation in Patient Care 5Health News:Fred Hutchinson Cancer Research Center Announces the First-Ever Expedition to an Unclimbed Mountain in the Name of Cancer Research 2Health News:For Some, Diabetes Care Worse Than Illness Itself 2
(Date:12/17/2014)... Revenue and earnings above the previous year - ... In the past 2013/14 fiscal year (ended 30 September ... 4.287 billion (last year: EUR 4.190 billion) despite unfavorable currency ... million. "Overall, 2013/14 was a successful fiscal year for the ... CEO of Carl Zeiss AG. "Thanks to our broad portfolio ...
(Date:12/17/2014)... , Dec. 17, 2014 With ... (MRI), the MRI market is seeing new growth, ... breast MRI scans account for the majority of ... higher resolution of images, which are creating opportunities for ... (MRI) market is growing at a rate of ...
(Date:12/17/2014)... 17, 2014  ImmunoCellular Therapeutics, Ltd. ("ImmunoCellular") (NYSE ... Trademark Office (USPTO) has issued a key patent ... immunotherapeutic vaccine targeting six tumor antigens that are ... Patent No. 8,871,211, which issued October 28, 2014, ... a dendritic cell composition comprising peptide epitopes of ...
Breaking Medicine Technology:ZEISS Asserts its Position in Difficult Environment 2Kalorama: 3T Advancements Bringing New Growth to the MRI Market 2Kalorama: 3T Advancements Bringing New Growth to the MRI Market 3ImmunoCellular Therapeutics Announces Issuance of Key Patent For ICT-107 Cancer Vaccine 2
... 2011 Actavis Group, the international generic pharmaceuticals company, today ... a binding letter of intent (LOI) with QRxPharma Limited (ASX: ... United States.  Under the terms of the ... IR, a patented 3:2 ratio fixed dose combination of morphine ...
...  QRxPharma Limited (ASX: QRX and OTCQX: QRXPY) announced today execution ... for the formation of a strategic partnership to commercialise MoxDuo ... IR is a patented 3:2 ratio fixed dose combination of ... Group, hf a privately held company based in Europe with ...
Cached Medicine Technology:Actavis to Launch Novel Pain Medication in the US 2Actavis to Launch Novel Pain Medication in the US 3QRxPharma Announces Strategic Partnership with Actavis 2QRxPharma Announces Strategic Partnership with Actavis 3QRxPharma Announces Strategic Partnership with Actavis 4QRxPharma Announces Strategic Partnership with Actavis 5
0.2 mm hook with curved shaft to reach over lens optic. Flat serrated handle with polished finish. Overall length: 4.8 inches. Most popular size or model....
0.2 mm, 90o angled tip with curved 9 mm shaft. Flat smooth handle with polished finish. Overall length: 4.5 inches....
Angled 45 degrees, 10 mm shaft with 0.2 mm tip. Round knurled handle with dull finish. Overall length: 4.6 inches....
2.0 mm cup. Angled 45 degree shaft 8 mm from tip to bend with flat handle and polished finish. Overall length: 4.8 inches....
Medicine Products: